Category: Exactech Inc.
Exactech beats Wall Street expectations with its 3rd-quarter results and raises its earnings outlook for the rest of the year.
Exactech (NSDQ:EXAC) beat Wall Street's expectations with its 3rd-quarter earnings and adjusted its outlook for the rest of the year.
Insulet Corp. hires the former director of Clinical Research & Technology for the Sansum Diabetes Research Institute, Dr. Howard Zisser, as its 1st medical director.
Insulet (NSDQ:PODD) said it named Dr. Howard Zisser, the former clinical director of the Sansum Diabetes Research Institute, as its 1st medical director.
Considered a leader in diabetes research, Zisser will be involved with a variety of clinical research projects and serve as a medical liaison between Insulet and government leaders, the FDA, and healthcare organizations, Bedford, Mass.-based Insulet said.
Smith & Nephew wants rival orthopedics devices maker Exact Surgical to pay $1 million for "willful and intentional" violations of a former sales rep's non-compete and nondisclosure agreements.
Orthopedic titan Smith & Nephew (FTSE:SN, NYSE:SNN) sued rival device maker Exact Surgical for $1 million dollars for hiring a former S&M rep to sell orthopedic devices in Texas.
Thoratec leaves Wall Street analysts in the dust with its 1st quarter earnings, beating expectations by 10¢, but the initial bump fades as investors back off after sending shares up more than 7% this morning; also, Allergan's Q1 sales rise, earnings soar; Endologix's sales spike, losses soar; Q1 profits plunge for Greatbatch; Hospira's Q1 sales slip, earnings slide; ResMed's Q3 sales, earnings up; and more.
Thoratec (NSDQ:THOR) started today up 7.2% as investors reacted to its stellar 1st-quarter numbers, but by the time the market closed THOR shares had fallen back to Earth to close at $34.46, down 0.1%.
The heart pump maker posted profits of $25.5 million, or 43¢ per diluted share, on sales of $126.8 million for the 3 months ended March 31.
, Cardica Inc.
, Dentsply International Inc.
, Digirad Corp.
, DJO Global Inc.
, Endologix Inc.
, Greatbatch Inc.
, Hamilton Thorne Inc.
, Hospira Inc.
, ResMed Inc.
, Thoratec Corp.
, Allergan Inc.
Medtronic enrolls the initial patient into its Medtronic Registry for Epilepsy to look at the long-term efficacy and safety of deep brain stimulation therapy for patients with drug-resistant epilepsy.
MASSDEVICE ON CALL — As neuromodulation therapy celebrates its 25th year, Medtronic (NYSE:MDT) enrolled the 1st patient into its Medtronic Registry for Epilepsy, a database tracking the safety, efficacy and quality of life of patients receiving deep-brain stimulation for treatment of drug-resistant epilepsy.
Zimmer president & CEO David Dvorak becomes the chairman of the board for medical device industry lobby AdvaMed, a position previously slated for ex-Stryker CEO Stephen MacMillan; plus VasoStitch forms scientific advisory board; Exactech re-ups contract with chairman & CEO; BioDrain announces new director; ValveXchange names chairman; Elron Electronics appoints new external director; Syneron adds to board; MichBio names director of marketing & communications; Derma Sciences renews deals with executives.
Zimmer CEO Dvorak becomes chair of AdvaMed
, Exactech Inc.
, BioDrain Medical Inc.
, Derma Sciences Inc.
, Elron Electronic Industries
, Stryker Corp.
, Syneron Medical Ltd.
, ValveXchange Inc.
Angeion makes up for sagging European sales by focusing on group purchasing organizations and service revenues in Q1; also, Natus Medical's earnings plunge; Mindray posts big boosts to top, bottom lines; iCad narrows quarterly losses; MiMedx sales soar in 2011; InSite's sales slide, losses widen; Exactech's bottom line shrinks; Viking boosts sales, widens losses; MedPro cuts losses; and Alphatec dives deeper into the red.
Angeion Corp. (NSDQ:ANGN) narrowed its 1st-quarter losses despite flat sales for the 3 months ended Jan. 31.
Although dragged down by a tough European climate, focusing on group purchasing organization and service revenues kept the company's sales from sliding, the cardiorespiratory diagnostic systems maker said.